|1.||Pertsemlidis, Alexander: 1 article (04/2015)|
|2.||Frolova, Liliya V: 1 article (04/2015)|
|3.||Mathieu, Véronique: 1 article (04/2015)|
|4.||Cimmino, Alessio: 1 article (04/2015)|
|5.||Rogelj, Snezna: 1 article (04/2015)|
|6.||De Carvalho, Annelise: 1 article (04/2015)|
|7.||Kornienko, Alexander: 1 article (04/2015)|
|8.||Evidente, Antonio: 1 article (04/2015)|
|9.||Masi, Marco: 1 article (04/2015)|
|10.||Kiss, Robert: 1 article (04/2015)|
01/01/1988 - "Effect of pretazettine and viva-natural, a dietary seaweed extract, on spontaneous AKR leukemia in comparison with standard drugs."
01/01/1979 - "A narcissus alkaloid, pretazettine hydrochloride (PTZ) has been shown to be active against spontaneous AKR leukemia. "
01/01/1979 - "Therapeutic activity of pretazettine, a narcissus alkaloid, on spontaneous AKR leukemia."
01/01/1978 - "Therapeutic activity of pretazettine on Rauscher leukemia: combination of antiviral activity and cellular protein inhibition."
01/01/1988 - "Antileukemic activity of pretazettine hydrochloride (PTZ: a narcissus alkaloid) and Viva-Natural (a seaweed extract) has been confirmed against spontaneous AKR T cell leukemia in mice containing 20% of advanced leukemia. "
|2.||Lewis Lung Carcinoma
01/01/1986 - "We reported previously that pretazettine hydrochloride (PTZ), a narcissus alkaloid, was found to be active against intraperitoneally implanted Lewis lung carcinoma. "
01/01/1986 - "Therapeutic potentials of pretazettine, standard anticancer drugs, and combinations on subcutaneously implanted Lewis lung carcinoma."
01/01/1983 - "Therapeutic effectiveness of pretazettine (PTZ) has been demonstrated in the intraperitoneally (i.p.) implanted Lewis lung carcinoma (LLC) in both syngeneic and allogeneic mice. "
01/01/1983 - "Therapeutic activity of pretazettine, standard drugs, and the combinations on intraperitoneally implanted Lewis lung carcinoma in mice."
01/01/1981 - "Therapeutic activity of pretazettine on Lewis lung carcinoma."
|3.||T-Cell Leukemia (Leukemia, T Cell)
01/01/2009 - "Trisphaeridine and pretazettine increased the intracellular Rh-123 concentration 30- and 50-fold, respectively, as compared to the non-treated cells, and 2-O-acetyllycorine and trisphaeridine were demonstrated by means of the checkerboard method to enhance the antiproliferative activity of doxorubicin on L5178 MDR mouse lymphoma cells. "